These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 16638624)
1. Aberrant accumulation of serotonin in dopaminergic neurons. Mössner R; Simantov R; Marx A; Lesch KP; Seif I Neurosci Lett; 2006 Jun; 401(1-2):49-54. PubMed ID: 16638624 [TBL] [Abstract][Full Text] [Related]
2. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. Cases O; Lebrand C; Giros B; Vitalis T; De Maeyer E; Caron MG; Price DJ; Gaspar P; Seif I J Neurosci; 1998 Sep; 18(17):6914-27. PubMed ID: 9712661 [TBL] [Abstract][Full Text] [Related]
3. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Zhou FC; Lesch KP; Murphy DL Brain Res; 2002 Jun; 942(1-2):109-19. PubMed ID: 12031859 [TBL] [Abstract][Full Text] [Related]
4. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347 [TBL] [Abstract][Full Text] [Related]
5. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors. Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters. Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177 [TBL] [Abstract][Full Text] [Related]
7. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. Salichon N; Gaspar P; Upton AL; Picaud S; Hanoun N; Hamon M; De Maeyer E; Murphy DL; Mossner R; Lesch KP; Hen R; Seif I J Neurosci; 2001 Feb; 21(3):884-96. PubMed ID: 11157075 [TBL] [Abstract][Full Text] [Related]
8. Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice. Owesson CA; Hopwood SE; Callado LF; Seif I; McLaughlin DP; Stamford JA Eur J Neurosci; 2002 May; 15(9):1516-22. PubMed ID: 12028362 [TBL] [Abstract][Full Text] [Related]
9. Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice. Yu Q; Teixeira CM; Mahadevia D; Huang Y; Balsam D; Mann JJ; Gingrich JA; Ansorge MS Mol Psychiatry; 2014 Jun; 19(6):688-98. PubMed ID: 24589889 [TBL] [Abstract][Full Text] [Related]
10. The aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake. Godar SC; Bortolato M; Castelli MP; Casti A; Casu A; Chen K; Ennas MG; Tambaro S; Shih JC J Psychiatr Res; 2014 Sep; 56():1-9. PubMed ID: 24882701 [TBL] [Abstract][Full Text] [Related]
11. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. Alexandre C; Popa D; Fabre V; Bouali S; Venault P; Lesch KP; Hamon M; Adrien J J Neurosci; 2006 May; 26(20):5554-64. PubMed ID: 16707806 [TBL] [Abstract][Full Text] [Related]
12. The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-Hooded rats: a quantitative autoradiography study. Chen F; Lawrence AJ Brain Res; 2003 Jun; 976(1):22-9. PubMed ID: 12763618 [TBL] [Abstract][Full Text] [Related]
13. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Fabre V; Beaufour C; Evrard A; Rioux A; Hanoun N; Lesch KP; Murphy DL; Lanfumey L; Hamon M; Martres MP Eur J Neurosci; 2000 Jul; 12(7):2299-310. PubMed ID: 10947809 [TBL] [Abstract][Full Text] [Related]
14. The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes. Hagan CE; Schenk JO; Neumaier JF Synapse; 2011 Oct; 65(10):1015-23. PubMed ID: 21437992 [TBL] [Abstract][Full Text] [Related]
15. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity. Mannoury la Cour C; Boni C; Hanoun N; Lesch KP; Hamon M; Lanfumey L J Neurosci; 2001 Mar; 21(6):2178-85. PubMed ID: 11245702 [TBL] [Abstract][Full Text] [Related]
16. A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Olivier JD; Van Der Hart MG; Van Swelm RP; Dederen PJ; Homberg JR; Cremers T; Deen PM; Cuppen E; Cools AR; Ellenbroek BA Neuroscience; 2008 Mar; 152(3):573-84. PubMed ID: 18295409 [TBL] [Abstract][Full Text] [Related]
17. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. Verrico CD; Miller GM; Madras BK Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332 [TBL] [Abstract][Full Text] [Related]